Rigel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $57,596 | $55,307 | $36,841 | $29,534 |
Gross Profit | 51,807 | 47,281 | 34,034 | 27,509 |
EBITDA | 17,781 | 15,092 | 1,060 | -5,973 |
EBIT | 17,177 | 14,481 | 447 | -6,373 |
Net Income | 14,341 | 12,421 | -1,030 | -8,247 |
Net Change In Cash | 57,596 | 55,307 | 36,841 | 29,534 |
Free Cash Flow | 14,477 | 22,029 | 80 | -5,151 |
Cash | 56,746 | 51,692 | 36,053 | 25,574 |
Basic Shares | 17,687 | 17,648 | 17,549 | 17,520 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $179,278 | $116,882 | $120,242 | $149,236 |
Gross Profit | 160,631 | 109,772 | 118,493 | 148,153 |
EBITDA | 28,512 | -16,981 | -53,868 | -11,287 |
EBIT | 26,284 | -18,219 | -54,866 | -12,449 |
Net Income | 17,485 | -25,091 | -61,596 | -17,914 |
Net Change In Cash | 179,278 | 116,882 | 120,242 | 149,236 |
Cost of Revenue | 5,569 | -11,483 | ||
Free Cash Flow | 31,435 | -20,743 | -74,208 | 5,251 |
Cash | 56,746 | 32,786 | 24,459 | 18,890 |
Basic Shares | 17,687 | 17,401 | 17,240 | 17,049 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.80 |
2024-09-30 | $0.70 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.05 |
